Wakefield Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Wakefield Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	14,408 +214	+2%	+$21.9K	0.31%	99
2026 Q1	$1.55M	Buy	14,194 +261	+2%	+$24.9K	0.41%	68
2025 Q4	$1.13M	Buy	+13,933	New	+$1.2M	0.31%	101
2025 Q2	–	Sell	-11,091	Closed	-$931K	–	228
2025 Q1	$931K	Sell	11,091 -3,157	-22%	-$294K	0.28%	123
2024 Q4	$1.31M	Sell	14,248 -54	-0.4%	-$5.19K	0.44%	66
2024 Q3	$1.33M	Sell	14,302 -201	-1%	-$17.4K	0.43%	68
2024 Q2	$1.19M	Sell	14,503 -231	-2%	-$17K	0.42%	63
2024 Q1	$978K	Buy	14,734 +82	+0.6%	+$5.06K	0.34%	85
2023 Q4	$832K	Buy	14,652 +1,500	+11%	+$78.6K	0.31%	106
2023 Q3	$717K	Buy	+13,152	New	+$779K	0.32%	88
2021 Q4	–	Sell	-15,231	Closed	-$809K	–	170
2021 Q3	$809K	Sell	15,231 -517	-3%	-$29.1K	0.3%	95
2021 Q2	$961K	Buy	15,748 +26	+0.2%	+$1.38K	0.36%	77
2021 Q1	$767K	Sell	15,722 -611	-4%	-$28.6K	0.31%	105
2020 Q4	$661K	Buy	+16,333	New	+$584K	0.28%	110

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wakefield Asset Management's LMAT Position: Q2 2026 in Review

Wakefield Asset Management increased its LeMaitre Vascular (LMAT) stake by 1.5% in Q2 2026, buying an estimated $21.9K and bringing the position to 14,408 shares worth $1.38M. The position accounts for 0.31% of the portfolio, ranked #99.

Wakefield Asset Management first reported a position in LMAT in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.55M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Wakefield Asset Management held 14,408 shares of LeMaitre Vascular worth $1.38M as of Q2 2026.
Wakefield Asset Management bought 214 LeMaitre Vascular shares in Q2 2026, an estimated $21.9K.
LeMaitre Vascular made up 0.31% of Wakefield Asset Management's portfolio in Q2 2026, its #99 holding.
Wakefield Asset Management first reported a position in LeMaitre Vascular in Q4 2020 and has held it in 14 quarters since.
Wakefield Asset Management's LeMaitre Vascular position peaked at $1.55M in Q1 2026.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Wakefield Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.